PET-CT for radiotherapy treatment planning and response monitoring in solid tumors (Q37832131)

24 August 2017

1 reference

title

PET-CT for radiotherapy treatment planning and response monitoring in solid tumors (English)

1 reference

Adaptive radiation therapy

24 August 2017

0 references

4

Wim J G Oyen

1 reference

24 August 2017

1

Johan Bussink

1 reference

24 August 2017

Johannes H A M Kaanders

series ordinal

2

1 reference

24 August 2017

Winette T A van der Graaf

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

25 January 2011

1 reference

Nature Reviews Clinical Oncology

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

4

1 reference

24 August 2017

233-242

1 reference

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2010.218

24 August 2017

0 references

cites work

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Hypoxic radiosensitization: adored and ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Predictive biomarker validation in practice: lessons from real trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

ARCON: a novel biology-based approach in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Intra-tumoural microvessel density in human solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

PET-CT for response assessment and treatment adaptation in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

A systematic methodology review of phase I radiation dose escalation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The role of double-strand break repair — insights from human genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Dependence of FDG uptake on tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

PET scans in radiotherapy planning of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Molecular imaging of solid tumors: exploiting the potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Nitroimidazoles and imaging hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

A marker for hypoxic cells in tumours with potential clinical applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Molecular aspects of tumour hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The histological structure of some human lung cancers and the possible implications for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Hypoxic cell turnover in different solid tumor lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Theragnostic imaging for radiation oncology: dose-painting by numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Molecular Imaging of Hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Modern techniques in radiological imaging related to oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

The hazard of accelerated tumor clonogen repopulation during radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.218

On respiratory impairment in cancer cells

31 March 2020

1 reference

12 December 2020

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

12 December 2020

Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.

1 reference

12 December 2020

PET-based treatment planning in radiotherapy: a new standard?

1 reference

12 December 2020

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

1 reference

12 December 2020

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

10.1038/NRCLINONC.2010.218

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

0 references

1 reference